AbbVie Inc.

Last update: Mar 25, 2026 at 04:53

About AbbVie Inc.

AbbVie Inc. is a research-based biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative medicines and therapies worldwide. Headquartered in North Chicago, Illinois, and founded in 2012 as a spin-off from Abbott Laboratories, it employs approximately 55,000 people and operates primarily in the pharmaceuticals and biotechnology sector. Key products include Humira, a leading treatment for autoimmune diseases such as rheumatoid arthritis, Crohn's disease, and psoriasis; Skyrizi and Rinvoq for immunology indications like plaque psoriasis and ulcerative colitis; Imbruvica for blood cancers; and Botox for neurological conditions and aesthetics following the 2020 Allergan acquisition. AbbVie Inc. maintains a robust pipeline addressing immunology, oncology, neuroscience, and other therapeutic areas, with recent advancements in treatments for essential tremor and kidney disease. Its global presence underscores its significant role in advancing healthcare solutions and contributing to the biopharmaceutical industry's growth.

Dividend Overview

Dividend Yield

3.00%

Annual Dividend

$6.65

Frequency

Quarterly

Payout Ratio

276.79%

FCF Payout Ratio

65.43%

Stock Price

$205.20

52-Week Range

$164.39 – $244.81

Dividend Health Score

Caution

Dividend Health Assessment

ABBV's dividend shows some areas that warrant monitoring. Strengths include a 6225.0% return on equity & 34.1% operating margin. Areas of concern: 276.8% earnings payout ratio & 0.7x current ratio. As a Dividend Aristocrat with 25+ consecutive years of increases, ABBV has a proven commitment to shareholders.

Based on 15 of 15 metrics

Payout & Coverage

Caution

Earnings Payout Ratio

276.8%Danger

FCF Payout Ratio

65.4%Caution

CFO Payout Ratio

58.5%Caution

Interest Coverage

3.3xCaution

Balance Sheet

Warning

Net Debt / Total Assets

46.5%Caution

Current Ratio

0.7xDanger

Debt-to-Equity

-21.2Danger

Profitability

Safe

Return on Equity

6225.0%Very Safe

Operating Margin

34.1%Very Safe

Gross Margin

72.6%Very Safe

Profit Margin Stability

VolatileWarning

Dividend Track Record

Very Safe

Dividend Streak

Aristocrat (25+ yrs)Very Safe

Dividend Cut

NoneVery Safe

5-Year Dividend CAGR

6.8%Safe

Earnings Stability

StableSafe

Dividend History (2016–2025)

ABBV annual dividend per share and yield history

Earnings & Profitability

ABBV earnings per share and net profit margin

Key Dates

Next Ex-Dividend Date

April 15, 2026

Next Payment Date

May 15, 2026

Dividend Growth

3-Year Dividend CAGR

5.17%

5-Year Dividend CAGR

6.81%

10-Year Dividend CAGR

12.50%

3-Year Total Growth

16.31%

5-Year Total Growth

38.98%

10-Year Total Growth

224.75%

Dividend Aristocrat (25+ yrs)

This company has increased its dividend for 25+ consecutive years.

Income Calculator

ABBV Dividend Calculator

Number of Shares

Total Investment

$20,520.00

Annual Income

$665.00

Quarterly Income

$166.25

Monthly Income

$55.42

Similar Dividend Stocks

Stock	Yield	5Y CAGR	Price	Sector
ABBV	3.00%	6.81%	$205.20	Healthcare
AMGNAmgen Inc.	2.68%	8.27%	$348.43	Healthcare
GILDGilead Sciences Inc.	2.20%	3.04%	$138.11	Healthcare
JNJJohnson & Johnson	2.14%	5.25%	$235.27	Healthcare
MRKMerck & Co., Inc.	2.84%	6.75%	$116.37	Healthcare
PFEPfizer Inc.	6.46%	3.59%	$26.96	Healthcare
UNHUnitedHealth Group Incorporated	3.10%	12.57%	$272.28	Healthcare

Frequently Asked Questions

What is ABBV's current dividend yield?

AbbVie Inc. (ABBV) currently has a dividend yield of 3.00%, based on a stock price of $205.20 and an annual dividend of $6.65.

When is ABBV's next dividend payment date?

ABBV's next ex-dividend date is 2026-04-15 and the next payment date is 2026-05-15. You must own the stock before the ex-dividend date to receive the upcoming payment.

How much does ABBV pay in dividends per year?

AbbVie Inc. paid $6.56 per share in annual dividends in 2025. The dividends are paid quarterly.

Has ABBV been increasing its dividend?

Yes, AbbVie Inc. is a Dividend Aristocrat (25+ yrs). Its dividend has grown at a 5-year CAGR of 6.81%, a 3-year CAGR of 5.17% and a 10-year CAGR of 12.50%.

Is ABBV's dividend safe?

AbbVie Inc. has a payout ratio of 276.79%. Its free cash flow payout ratio is 65.43%. The payout ratio is above 100%, which may indicate the company is paying more in dividends than it earns. This could be unsustainable long-term.

How is ABBV's Dividend Health Score calculated?

The Dividend Health Score evaluates AbbVie Inc.'s dividend sustainability across four categories: Payout & Coverage (40%), Balance Sheet (20%), Profitability (20%), and Dividend Track Record (20%). Each metric is rated from "Very Safe" to "Danger" based on industry-standard thresholds, with sector-specific adjustments for healthcare companies. The overall score ranges from 0 to 100.

Want to understand how we rate dividend safety? Read our full methodology

Track ABBV Dividends with OnlyDividends

What will ABBV actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.

This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.

Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Health Score, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.

Market data provided by Twelve Data.